Tata Elxsi Limited has informed the Exchange regarding a press release dated May 27, 2026, titled "Please find enclosed the Press Release dated May 27, 2026, titled Tata Elxsi Launches AnaTel , an AI-Native Software Development Platform for Healthcare and Med-Tech Powered by OpenAna .".
TATAELXSI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tata Elxsi has launched AnaTel, an AI-native software development platform for healthcare and medical technology companies, co-developed with OpenAna. The platform embeds autonomous AI agents into engineering workflows to help medical device and SaMD companies generate regulatory-grade documentation and accelerate software development. Key claims include reducing development cycle times by up to 60% and cutting SaMD development timelines from 8 weeks to 72 hours. The platform generates code, documentation, test cases, and regulatory artifacts while keeping human engineers in control at critical decision points. It supports compliance with FDA and European regulatory requirements. The launch is being presented at DeviceTalks Boston 2026.
This is a new product launch in the healthcare and medtech segment, expanding Tata Elxsi's AI-powered service offerings. While it demonstrates innovation capability, no specific revenue impact or contract values are disclosed in this announcement.